ifenprodil has been researched along with dm 235 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Fukunaga, K; Moriguchi, S; Narahashi, T; Tanaka, T | 1 |
2 other study(ies) available for ifenprodil and dm 235
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Novel nootropic drug sunifiram enhances hippocampal synaptic efficacy via glycine-binding site of N-methyl-D-aspartate receptor.
Topics: Animals; CA1 Region, Hippocampal; Dose-Response Relationship, Drug; Electrodes, Implanted; Excitatory Amino Acid Antagonists; Glycine; Kynurenic Acid; Long-Term Potentiation; Male; Mice; Mice, Inbred C57BL; Nootropic Agents; Piperazines; Piperidines; Polyamines; Protein Binding; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2013 |